Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
Leukemia|April 20, 2022
GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activityMichelle J Cox, Claudia Manriquez Roman, Erin E Tapper, et al.
Neuro-Oncology Advances|October 16, 2023
Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patientsM J Webb, Bryan J Neth, Lauren M Webb, et al.
Medrxiv : the Preprint Server for Health Sciences|April 29, 2025
Cerebrospinal fluid D-2-hydroxyglutarate for IDH-mutant glioma: utility for detection versus monitoringCecile Riviere-Cazaux, Yuta Suzuki, Zain Kizilbash, et al.
Neuro-Oncology Advances|March 19, 2026
Cerebrospinal fluid D-2-hydroxyglutarate for IDH-mutant glioma monitoringCecile Riviere-Cazaux, Yuta Suzuki, Zain Kizilbash, et al.
Frontiers in Oncology|August 29, 2025
Analysis of imaging signatures in 18F-DOPA PET of glioblastoma treated with dose-escalated radiotherapyJing Qian, Deanna H Pafundi, William G Breen, et al.
Cancers|November 13, 2025
Predicting Remaining Survival of Glioblastoma Patients with Radiomics Analysis Based on 18F-DOPA PET ImagesJing Qian, Deanna Hasenauer, William G Breen, et al.
JAMA Neurology|December 22, 2018
Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein AutoantibodyDivyanshu Dubey, Sean J Pittock, Karl N Krecke, et al.
Neurology. Genetics|September 8, 2016
KCNQ2 encephalopathy: Features, mutational hot spots, and ezogabine treatment of 11 patientsJohn J Millichap, Kristen L Park, Tammy Tsuchida, et al.
Molecular Genetics and Metabolism Reports|June 16, 2025
Efficacy results from a 12-month double-blind randomized trial of arimoclomol for treatment of Niemann-Pick disease type C (NPC): Presenting a rescored 4-domain NPC Clinical Severity ScaleEugen Mengel, Marc C Patterson, Rosalia M Da Riol, et al.
Molecular Genetics and Metabolism|February 17, 2015
Disease specific therapies in leukodystrophies and leukoencephalopathiesGuy Helman, Keith Van Haren, Joshua L Bonkowsky, et al.
Pageof 16